Moreover, Survivin [148] and GGT1 [149] showed higher serum sEV activity in PCa patients compared to BPH patients, suggesting that serum sEV Survivin/GGT activity may serve as a potential biomarker for PCa. The gene discussed is GGT1; the disease is posterior cortical atrophy.